Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hsieh

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Biomolecular Structure & Dynamics|October 2, 2002
Flexibility of BIV TAR-Tat: models of peptide bindingMark Hsieh, Elaine D Collins, Thomas Blomquist, et al.
Journal of the American Pharmacists Association : Japha|April 12, 2024
Evaluating trends in pharmacist e-prescribing: 2019-2022Shannon Reidt, Mark Hsieh, Joud Roufael, et al.
Antibodies (Basel, Switzerland)|March 6, 2021
Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and CorrectionCarl Mieczkowski, Alan Cheng, Thierry Fischmann, et al.
Antibodies (Basel, Switzerland)|December 3, 2020
Crystal Structure and Characterization of Human Heavy-Chain Only Antibodies Reveals a Novel, Stable Dimeric Structure Similar to Monoclonal AntibodiesCarl Mieczkowski, Soheila Bahmanjah, Yao Yu, et al.
Mabs|April 7, 2020
Predicting Antibody Developability Profiles Through Early Stage Discovery ScreeningMarc Bailly, Carl Mieczkowski, Veronica Juan, et al.
Communications Biology|July 30, 2021
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of actionRachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
Journal for Immunotherapy of Cancer|August 19, 2025
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapyThierry O Fischmann, Daniel Malashock, Eunseon Ahn, et al.
Molecular Cancer Therapeutics|April 2, 2020
Biophysical and Immunological Characterization and <i>In Vivo</i> Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody PembrolizumabBeth Hutchins, Gary C Starling, Mark A McCoy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Biomolecular Structure & Dynamics|October 2, 2002
Flexibility of BIV TAR-Tat: models of peptide bindingMark Hsieh, Elaine D Collins, Thomas Blomquist, et al.
Journal of the American Pharmacists Association : Japha|April 12, 2024
Evaluating trends in pharmacist e-prescribing: 2019-2022Shannon Reidt, Mark Hsieh, Joud Roufael, et al.
Antibodies (Basel, Switzerland)|March 6, 2021
Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and CorrectionCarl Mieczkowski, Alan Cheng, Thierry Fischmann, et al.
Antibodies (Basel, Switzerland)|December 3, 2020
Crystal Structure and Characterization of Human Heavy-Chain Only Antibodies Reveals a Novel, Stable Dimeric Structure Similar to Monoclonal AntibodiesCarl Mieczkowski, Soheila Bahmanjah, Yao Yu, et al.
Mabs|April 7, 2020
Predicting Antibody Developability Profiles Through Early Stage Discovery ScreeningMarc Bailly, Carl Mieczkowski, Veronica Juan, et al.
Communications Biology|July 30, 2021
Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of actionRachel L Palte, Veronica Juan, Yacob Gomez-Llorente, et al.
Journal for Immunotherapy of Cancer|August 19, 2025
Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapyThierry O Fischmann, Daniel Malashock, Eunseon Ahn, et al.
Molecular Cancer Therapeutics|April 2, 2020
Biophysical and Immunological Characterization and <i>In Vivo</i> Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody PembrolizumabBeth Hutchins, Gary C Starling, Mark A McCoy, et al.
Pageof 1